A phase 1 Clinical Trial to Evaluate Safety and Immunogenecity of HIV SOSIP v8.2 763 Vaccine in healthy individuals

2025-520529-19-00 Protocol HIVIC-FOUND Human pharmacology (Phase I) - First administration to humans Ended

Start 20 May 2026 · End 21 May 2026 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol HIVIC-FOUND

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 12
Countries 1
Sites 1

Human Immunodeficiency Virus (HIV)

Key facts

Sponsor
Consorcio Centro De Investigacion Biomedica En Red
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Virus Diseases [C02]
Trial duration
20 May 2026 → 21 May 2026
Decision date (initial)
2025-01-16
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2025-520529-19-00
EudraCT number
2021-003868-27

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Human Immunodeficiency Virus (HIV)

VersionLevelCodeTermSystem organ class
20.1 PT 10020161 HIV infection 100000004862
20.0 SOC 10021881 Infections and infestations 1

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Consorcio Centro De Investigacion Biomedica En Red

Sponsor organisation
Consorcio Centro De Investigacion Biomedica En Red
Address
Pab 11, Avenida De Monforte De Lemos 3-5 Avenida De Monforte De Lemos 3-5
City
Madrid
Postcode
28029
Country
Spain

Scientific contact point

Organisation
Consorcio Centro De Investigacion Biomedica En Red
Contact name
Dr. Josep Mallolas

Public contact point

Organisation
Consorcio Centro De Investigacion Biomedica En Red
Contact name
Dr. Josep Mallolas

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ended 12 1
Rest of world 0

Investigational sites

Spain

1 site · Ended
Hospital Clinic De Barcelona
HIV Unit, Calle Villarroel 170, 08036, Barcelona

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2026-05-20 2026-05-21 2026-05-20 2026-05-20

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-01-09 Spain Acceptable
2025-01-15
2025-01-16